Literature DB >> 34273687

Activation, development, and attenuation of modeling- and remodeling-based bone formation in adult rats.

Wenzheng Wang1, Wei-Ju Tseng2, Hongbo Zhao2, Tala Azar2, Shaopeng Pei2, Xi Jiang2, Nathaniel Dyment2, X Sherry Liu3.   

Abstract

Activation of modeling-based bone formation (MBF - bone formation without prior activation of bone resorption), has been identified as an important mechanism by which anabolic agents, such as intermittent parathyroid hormone (PTH), rapidly elicit new bone formation. Using a novel cryohistology imaging platform, coupled with sequential multicolor fluorochrome injections, we demonstrated that MBF and remodeling-based bone formation (RBF) in the adult rat tibia model have similar contributions to trabecular bone homeostasis. PTH treatment resulted in a 2.4-4.9 fold greater bone formation rate over bone surface (BFR/BS) by RBF and a 4.3-8.5 fold greater BFR/BS by MBF in male, intact female, and ovariectomized female rats. Moreover, regardless of bone formation type, once a formation site is activated by PTH, mineral deposition continues throughout the entire treatment duration. Furthermore, by tracking the sequence of multicolor fluorochrome labels, we discovered that MBF, a highly efficient but often overlooked regenerative mechanism, is activated more rapidly but attenuated faster than RBF in response to PTH. This suggests that MBF and RBF contribute differently to PTH's anabolic effect in rats: MBF has a greater contribution to the acute elevation in bone mass at the early stage of treatment while RBF contributes to the sustained treatment effect.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anabolic treatments; Animal model; Bone histomorphometry; Modeling- and remodeling-based bone formation; Osteoporosis

Mesh:

Substances:

Year:  2021        PMID: 34273687      PMCID: PMC8523222          DOI: 10.1016/j.biomaterials.2021.121015

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   15.304


  40 in total

1.  A method for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues.

Authors:  T Kawamoto; M Shimizu
Journal:  Histochem Cell Biol       Date:  2000-05       Impact factor: 4.304

2.  Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.

Authors:  Yanfei L Ma; Qingqiang Zeng; David W Donley; Louis-Georges Ste-Marie; J Christopher Gallagher; Gail P Dalsky; Robert Marcus; Erik Fink Eriksen
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

Review 3.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

4.  Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys.

Authors:  Rogely Waite Boyce; Qing-Tian Niu; Michael S Ominsky
Journal:  Bone       Date:  2017-04-18       Impact factor: 4.398

5.  Monitoring in vivo (re)modeling: a computational approach using 4D microCT data to quantify bone surface movements.

Authors:  Annette I Birkhold; Hajar Razi; Richard Weinkamer; Georg N Duda; Sara Checa; Bettina M Willie
Journal:  Bone       Date:  2015-03-04       Impact factor: 4.398

6.  Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts.

Authors:  Sang Wan Kim; Yanhui Lu; Elizabeth A Williams; Forest Lai; Ji Yeon Lee; Tetsuya Enishi; Deepak H Balani; Michael S Ominsky; Hua Zhu Ke; Henry M Kronenberg; Marc N Wein
Journal:  J Bone Miner Res       Date:  2017-01-30       Impact factor: 6.741

7.  Trabecular minimodeling in human iliac bone.

Authors:  S Kobayashi; H E Takahashi; A Ito; N Saito; M Nawata; H Horiuchi; H Ohta; A Ito; R Iorio; N Yamamoto; K Takaoka
Journal:  Bone       Date:  2003-02       Impact factor: 4.398

Review 8.  The cell biology of parathyroid hormone in osteoblasts.

Authors:  Stavroula Kousteni; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2008-06       Impact factor: 5.096

9.  Longitudinal Effects of Teriparatide or Zoledronic Acid on Bone Modeling- and Remodeling-Based Formation in the SHOTZ Study.

Authors:  David W Dempster; Hua Zhou; Valerie A Ruff; Thomas E Melby; Jahangir Alam; Kathleen A Taylor
Journal:  J Bone Miner Res       Date:  2018-02-23       Impact factor: 6.741

Review 10.  Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  David W Dempster; Juliet E Compston; Marc K Drezner; Francis H Glorieux; John A Kanis; Hartmut Malluche; Pierre J Meunier; Susan M Ott; Robert R Recker; A Michael Parfitt
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more
  1 in total

1.  Short Cyclic Regimen With Parathyroid Hormone (PTH) Results in Prolonged Anabolic Effect Relative to Continuous Treatment Followed by Discontinuation in Ovariectomized Rats.

Authors:  Wei-Ju Tseng; Wonsae Lee; Hongbo Zhao; Yang Liu; Wenzheng Wang; Chantal Mj de Bakker; Yihan Li; Carlos Osuna; Wei Tong; Luqiang Wang; Xiaoyuan Ma; Ling Qin; X Sherry Liu
Journal:  J Bone Miner Res       Date:  2022-01-20       Impact factor: 6.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.